HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Abeel A. Mangi Permission Requests Citing Articles Citing Articles via Google Scholar Google Scholar Articles by Mangi, A. A. Search for Related Content PubMed PubMed Citation Articles by Mangi, A. A. Related Collections Valve disease Related Article

---

Original Articles: Adult Cardiac

Invited Commentary

Department of Thoracic and Cardiovascular Surgery, Heart and Vascular Institute, Cleveland Clinic, 9500 Euclid Ave, Desk J-4–133, Cleveland, OH 44122

(Email: mangia@ccf.org).

The first 20% of the full text of this article appears below.

Recent reports have suggested that tricuspid valve repair performed at the time of mitral valve operation results in a lower incidence of advanced heart failure, defined as New York Heart Association (NHYA) functional class III or IV, and improves survival [1]. The operation is not without risk. One of those risks, as demonstrated by Jokinen and colleagues [2], is that almost one-quarter of patients undergoing a tricuspid valve operation (whether isolated or as part of a multiple valve operation) require . . . [Full Text of this Article]

Related Article

Pacemaker Therapy After Tricuspid Valve Operations: Implications on Mortality, Morbidity, and Quality of Life

Janne J. Jokinen, Anu K. Turpeinen, Otto Pitkänen, Mikko J. Hippeläinen, and Juha E.K. Hartikainen
Ann. Thorac. Surg. 2009 87: 1806-1814. [Abstract] [Full Text] [PDF]